Skinvisible Reports Unregistered Equity Sales
Ticker: SKVI · Form: 8-K · Filed: Jun 4, 2024 · CIK: 1085277
| Field | Detail |
|---|---|
| Company | Skinvisible, Inc. (SKVI) |
| Form Type | 8-K |
| Filed Date | Jun 4, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.10, $0.20 |
| Sentiment | neutral |
Sentiment: neutral
Topics: unregistered-sales, equity-securities, 8-k
Related Tickers: SKVI
TL;DR
SKVI sold unregistered equity, details TBD.
AI Summary
Skinvisible, Inc. filed an 8-K on June 4, 2024, reporting unregistered sales of equity securities. The filing does not specify the exact date of the sales or the dollar amounts involved, but it indicates a transaction occurred on or before June 4, 2024.
Why It Matters
This filing indicates potential dilution for existing shareholders as new equity has been issued without a public offering. Investors should monitor future filings for details on the terms and impact of these sales.
Risk Assessment
Risk Level: medium — Unregistered sales can lead to dilution and lack of transparency regarding the terms and valuation of the securities sold.
Key Players & Entities
- Skinvisible, Inc. (company) — Registrant
- 000-25911 (company) — SEC File Number
- 88-0344219 (company) — I.R.S. Employer Identification No.
- 6320 South Sandhill Road Suite 9, Las Vegas, NV 89120 (company) — Principal executive offices address
- 702-433-7154 (company) — Registrant's telephone number
FAQ
What type of equity securities were sold?
The filing states 'Unregistered Sales of Equity Securities' but does not specify the type of securities.
When did the unregistered sales of equity securities occur?
The filing reports the event as of June 4, 2024, indicating the sales occurred on or before this date.
What was the total dollar amount of the unregistered equity sales?
The filing does not disclose the specific dollar amount of the unregistered equity sales.
Were these sales made to accredited investors?
The filing does not provide details on the purchasers of the unregistered equity securities.
What is the purpose of these unregistered equity sales?
The filing does not state the specific purpose for the unregistered sales of equity securities.
Filing Stats: 502 words · 2 min read · ~2 pages · Grade level 11.2 · Accepted 2024-06-04 17:18:29
Key Financial Figures
- $0.10 — nvestors, where each unit was priced at $0.10 per unit and consists of one share of c
- $0.20 — from issuance with an exercise price at $0.20 per share. These securities were issue
Filing Documents
- skvi8k060324.htm (8-K) — 20KB
- 0001663577-24-000148.txt ( ) — 183KB
- skvi-20240604.xsd (EX-101.SCH) — 3KB
- skvi-20240604_lab.xml (EX-101.LAB) — 33KB
- skvi-20240604_pre.xml (EX-101.PRE) — 22KB
- skvi8k060324_htm.xml (XML) — 3KB
02 Unregistered Sales of Equity Securities
Item 3.02 Unregistered Sales of Equity Securities On June 4, 2024, we issued a total of 350,000 units to accredited investors, where each unit was priced at $0.10 per unit and consists of one share of common stock in the company and a warrant to purchase one-half of one share of common stock in the company, exercisable for one year from issuance with an exercise price at $0.20 per share. These securities were issued pursuant to Section 4(2) of the Securities Act and/or Rule 506 and/or Regulation S promulgated thereunder. The investor represented the intention to acquire the securities for investment only and not with a view towards distribution. The investor was given adequate information about us to make an informed investment decision. We did not engage in any general solicitation or advertising. We directed our transfer agent to issue the stock certificates with the appropriate restrictive legend affixed to the restricted stock. 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Skinvisible, Inc. /s/ Terry Howlett Terry Howlett Chief Executive Officer Date: June 4, 2024 3